The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of body mass index and karyotype on clinical outcomes in adolescents and young adults (AYA) with acute myeloid leukemia.
 
Mody Amin
No Relationships to Disclose
 
Erin Feliciano
No Relationships to Disclose
 
Melissa Fos
No Relationships to Disclose
 
Tara Cronin
No Relationships to Disclose
 
Pamela J Sung
No Relationships to Disclose
 
Steven Green
Consulting or Advisory Role - GlaxoSmithKline; SOBI
 
Elizabeth A. Griffiths
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Apellis Pharmaceuticals; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Genentech; Novartis; Otsuka; PicnicHealth; Taiho Oncology; Takeda
Research Funding - Alexion Pharmaceuticals; Apellis Pharmaceuticals (Inst); Astex Pharmaceuticals (Inst); AstraZeneca Rare Disease; Blueprint Medicines; Bristol-Myers Squibb/Celgene; Celgene (Inst); Celldex (Inst); Genentech (Inst); NextCure
Other Relationship - American Society of Hemotology; Aplastic Anemia and MDS International Foundation; MDS Foundation; Medicom Worldwide; Physicans' Education Resource
 
Amanda Przespolewski
Employment - Bristol-Myers Squibb
 
James E. Thompson
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Daiichi Sankyo/UCB Japan; Gilead Sciences; GlaxoSmithKline; Immunogen; Janssen; Kite/Gilead; Kura Oncology; Novartis; Nuprobe; Qiagen; Rigel; Schrodinger; Sellas Life Sciences; Sumitomo Pharma Oncology; Syndax
Speakers' Bureau - Astellas Pharma; DAVA Pharmaceuticals; Pfizer
Other Relationship - Abbvie/Genentech; Gilead Sciences; Gilead Sciences